Skip to content

In this study, we will assess spatiotemporal gait parameters and fall risk in cancer survivors with chemotherapy-induced peripheral neuropathy in comparison with healthy individuals

EXPLORING SPATIOTEMPORAL GAIT PARAMETERS AND FALL RISK IN CANCER SURVIVORS WITH CHEMOTHERAPY INDUCED PERIPHERAL NEUROPATHY

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/09/036320
Enrollment
64
Registered
2021-09-07
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G988- Other disorders of nervous system

Interventions

Intervention1: Cross-sectional, Two groups comparative study design: In this study, we will assess spatial parameters like step length, stride length, the width of BOS, and temporal parameters like ca

Sponsors

Amarjyoti Institue of physiotherapy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: • AGE CRITERIA Group A (Cancer survivors) - 18 to 60 years Group B (Healthy individuals) - 18 to 60 years • Physician confirmed the diagnosis of cancer • All types of cancer • Both gender • Received neo-adjuvant or adjuvant chemotherapy treatment • Able to walk for at least 10 feet.

Exclusion criteria

Exclusion criteria: • Hereditary peripheral neuropathy .{ eg, Charcot-marie-tooth disease} • Treatment with antiepileptic drugs, antidepressants and major analgesics. • Orthopaedic problem that affect balance { eg ACL reconstruction} • Vestibular disorder and Visual acuity problem . • Neurological conditions like Parkinsonâ??s disease , Ataxia • Chronic inflammatory demyelinating polyneuropathy • Concomitant Disease like diabetes, renal insufficiencies • Prior history of alcohol abuse • Lower limb amputee. • Use of walking aid • CIPN negative or Asymptomatic

Design outcomes

Primary

MeasureTime frame
â?¢ Step length â?¢ Width of BOS â?¢ Degree Of toe out â?¢ Cadence â?¢ Stride length â?¢ Walking velocity Timed up and go test [ TUG Test ]Timepoint: After screening on Day 1 cancer survivorâ??s and healthy individualâ??s spatiotemporal gait parameters and fall risk will be assessed then Later they will get compared between the obtained values of cancer survivorâ??s parameters the Normal parameters of healthy individuals

Secondary

MeasureTime frame
NoneTimepoint: None

Countries

India

Contacts

Public ContactPushpender kumar

Amar jyoti Institue of physiotherapy

nidhi.singh2411@gmail.com7042627025

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026